Curaleaf Holdings, Inc. (CURLF)
Curaleaf Holdings, Inc. (CURLF)
| Cash Flow | 2026-06-30 |
|---|---|
| Net income (loss) from continuing operations | 82,552 |
| Depreciation and amortization | 96,467 |
| Share-based compensation | 20,134 |
| Non-cash interest expense | 21,612 |
| Amortization of operating lease right-of-use assets | 9,893 |
| Loss on impairment | 41 |
| Loss (gain) on debt extinguishment and third party debt issuance costs | -4,494 |
| Deferred taxes | 81,770 |
| Other adjustments, net | 1,995 |
| Foreign exchange loss (gain) | -4,226 |
| Accounts receivable, net | -728 |
| Inventories | 18,481 |
| Prepaid expenses and other current assets | -8,057 |
| Income tax receivable | 0 |
| Net assets held for sale and discontinued operations | -375 |
| Other assets - net of current | -1,964 |
| Accounts payable | -14,188 |
| Accrued expenses and other liabilities | -3,272 |
| Income tax payable | -70,644 |
| Lease liabilities, operating | -9,888 |
| Net cash provided by operating activities from continuing operations | 50,305 |
| Net cash used in operating activities from discontinued operations | -61 |
| Net cash provided by operating activities | 50,244 |
| Purchases of property, plant and equipment | 32,915 |
| Disposals of property, plant and equipment | 0 |
| Acquisition-related cash payments, net of cash acquired | 0 |
| Purchases of intangibles | 287 |
| Purchase of investments | 0 |
| Issuance of notes receivable | 1,216 |
| Payments received on notes receivables | 583 |
| Dividend received on investments | 20 |
| Net cash used in investing activities from continuing operations | -33,815 |
| Net cash used in investing activities from discontinued operations | 0 |
| Net cash used in investing activities | -33,815 |
| Proceeds from notes payable | 426,511 |
| Principal payments on notes payable | 361,268 |
| Minority interest buyouts | 50,875 |
| Payments of debt issuance costs | 7,620 |
| Principal payments on finance lease liabilities | 6,031 |
| Principal payments on financial obligations | 4,570 |
| Exercise of stock options | 1,283 |
| Remittances of statutory withholdings on share-based payment awards | 6,459 |
| Payments to repurchase svs | 1,000 |
| Payments of deferred consideration | 618 |
| Payments of contingent consideration | 0 |
| Net cash used in financing activities from continuing operations | -10,647 |
| Net cash used in financing activities from discontinued operations | 0 |
| Net cash used in financing activities | -10,647 |
| Net increase (decrease) in cash and cash equivalents (including restricted cash) | 5,782 |
| Cash and cash equivalents (including restricted cash), beginning of period | 101,573 |
| Effect of exchange rate changes on cash and cash equivalents (including restricted cash) | -387 |
| Cash and cash equivalents (including restricted cash), end of period | 106,968 |